(Press-News.org) The Asian Fund for Cancer Research (AFCR) is thrilled to unveil its fresh brand logo and slogan, marking a pivotal moment in the organization's quest to advance breakthroughs in cancer globally. The redesigned emblem and impactful slogan firmly establish AFCR as a prominent voice in the ongoing battle against cancer, extending its influence beyond Asia.
"Advancing Cancer Breakthroughs from Asia to the World"
This compelling slogan powerfully encapsulates AFCR's unwavering commitment to drive innovation and foster collaboration in cancer research with a global impact. Accentuating the translation of discoveries from the vibrant laboratories of Asia to positively influence patients worldwide, the slogan illuminates AFCR's pivotal role in spearheading the international fight against cancer.
AFCR is acutely aware of the critical necessity to confront Asian-specific cancers—such as hepatocellular carcinoma (HCC), lung cancer, gastrointestinal (GI) cancer, esophageal cancer, and ovarian cancer. These unique challenges necessitate targeted research initiatives, and AFCR stands devoted to championing groundbreaking research projects, precisely tailored to these cancers. The AFCR mission extends beyond borders, aiming not only to enhance treatment modalities and improve early detection methods but also to establish collaborative networks that seamlessly facilitate knowledge sharing among researchers on a global scale.
Dr. Sujuan Ba, Founder, President & CEO of AFCR, expressed her excitement about the new logo and slogan, affirming, "Our revamped visual identity, coupled with the powerful slogan, signifies a significant stride in our dedication to propelling cancer research on a global scale. It reinforces our mission to connect Asian research initiatives with the worldwide effort against cancer."
As an example of the impact AFCR can provide to the cancer research community, in support of improved care for patients, AFCR is championing an innovative immunotherapy for gastrointestinal (GI) cancer, addressing a significant unmet clinical need. Leveraging the success of immunotherapy in certain cancers, AFCR supports a groundbreaking multi-targeting immunotherapeutic platform. This approach centers on the biomarker CDH17, highly expressed in 50-95% of GI cancers, making it an excellent target. The platform includes bi-specific antibodies that target both CDH17 and the CD3 marker on T cells, redirecting T cells to exert their cell-killing function on tumor cells. This novel immunotherapy offers a safer and more targeted solution for GI cancer patients, presenting a real breakthrough where no effective treatment existed before.Given the pressing health crisis posed by GI cancers globally, particularly in Asia, The program could offer potential safe and effective treatment for GI cancer where none was available previously. with the potential to save millions of lives worldwide.
AFCR's fresh brand logo is a catalyst for expanding engagement and diversifying support, strategically positioning the organization to propel its mission forward. As we look ahead, AFCR, with optimism and determination, anticipates exciting collaborations, groundbreaking discoveries, and a growing community committed to the fight against cancer. The logo not only reflects the organization's dedication but also points at a future where AFCR's impact resonates even more profoundly in the global battle against cancer.
###
About the Asian Fund for Cancer Research
The Asian Fund for Cancer Research (AFCR) is a nonprofit organization committed to combatting cancers that disproportionately affect Asian populations. Headquartered in Hong Kong and with a global reach, AFCR is uniquely positioned to investigate the unique causes of cancer in Asian demographics through innovative genetic and molecular research. The organization accelerates cutting-edge cancer research breakthroughs and technologies while developing more potent therapies for cancer patients across Asia and the world. Further insights can be found at www.AFCR.org.
END
Asian Fund for Cancer Research Limited unveils inspiring new logo and slogan, signifying a global commitment to advancing cancer research - from Asia to the world.
2023-12-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Beetroot juice supplement lowers blood pressure and improves exercise capacity in people with chronic obstructive pulmonary disease
2023-12-20
A 12-week course of daily beetroot juice supplement for people with chronic obstructive pulmonary disease (COPD) lowered blood pressure and improved how far patients could walk in six minutes in research published today (Wednesday) in the European Respiratory Journal [1].
COPD is a serious lung condition affecting around 400 million people worldwide [2]. COPD which includes chronic bronchitis and emphysema, causes breathing difficulties and severely limits people’s capacity for physical activity. It also increases the risk ...
Finding that statins could slow dementia stimulates further research
2023-12-20
Blood fat-lowering statins could slow the progression of Alzheimer's disease, at least for some patients. This is the result of a new study led by Karolinska Institutet published in Alzheimer Research and Therapy. But the researchers are cautious in their interpretations and see the results as a first step in a research journey that may eventually provide the answer.
A new study shows that people with Alzheimer's dementia deteriorated more slowly in their cognitive functions if they were also treated with a lipid-lowering ...
Potentially harmful ‘trip-killers’ to cut short ‘bad’ drug trips, emerging concern, warn doctors
2023-12-20
The use of potentially harmful ‘trip-killers’ to cut short ‘bad drug trips’ after taking psychedelics, such as LSD or magic mushrooms, is an emerging concern, warn doctors in a research letter, published online in Emergency Medicine Journal.
Their analysis of relevant threads on the social media platform Reddit, shows that drugs such as benzodiazepines (sedatives) and antipsychotics are the options most frequently recommended, but warnings about their potential side effects are rarely included, they highlight.
The intensity of a psychedelic drug trip can cause distress, agitation, ...
3 potentially unique acoustic features of healing music that transcend genre identified
2023-12-20
There are three potentially unique acoustic features of healing music that transcend musical genres, suggests research published in the open access journal General Psychiatry.
The findings might help to personalise playlists for patients, using artificial intelligence to analyse individual physiological and psychological responses, and help to evaluate the effectiveness of existing music therapies, suggest the researchers.
Despite evidence of the therapeutic effects of music for mental health issues, such as anxiety, depression, and post traumatic stress disorder, there’s no consensus on what defines healing ...
Diabetes drug may significantly lower women’s risk of substantial weight gain after giving up smoking
2023-12-20
The diabetes drug dulaglutide (Trulicity) may significantly lower a woman’s risk of substantial weight gain after she has given up smoking, finds a secondary analysis of clinical trial data, published in the open access journal BMJ Nutrition Prevention & Health.
Women seem to be 5 times as likely as men to put on a lot of weight after they’ve stubbed out what they intend to be their last cigarette, the analysis suggests.
Women seem to have higher smoking relapse rates than men. And it’s been suggested that one of the possible explanations for this is that they may be more concerned about ...
Antimicrobial resistance leads to more deaths and illnesses in the WHO African region than anywhere else
2023-12-20
SEATTLE, Wash., Dec. 19, 2023 ‑‑ Over 1.05 million deaths were associated with antimicrobial resistance (AMR) and 250,000 deaths were attributable to AMR in the WHO African region, posing an unprecedented health threat. That’s according to a new study published in The Lancet Global Health today.
The number of deaths linked to AMR in the WHO African region is higher than those caused by both HIV/AIDS (639,554) and malaria (594,348), marking a pivotal shift in the health challenges facing the region. Despite the relatively low prevalence of resistance, the WHO African region had the highest burden of AMR mortality, which ...
Groundbreaking discovery at Museums Victoria Research Institute rewrites our understanding of whale evolution
2023-12-20
Groundbreaking new research from the Museums Victoria Research Institute has turned upside down our previous understanding of the evolution of the largest animals ever––baleen whales.
Palaeontologists Dr James Rule (Monash University and Natural History Museum, London) and Dr Erich Fitzgerald (Museums Victoria Research Institute) have co-authored the open access paper ‘Giant baleen whales emerged from a cold southern cradle’, published today in the prestigious journal Proceedings of the Royal Society B.
Until now, it was believed that the beginning of the Ice Age in the ...
Scientists provide recipe to halve pollution from food production
2023-12-20
A major report for the United Nations has put forward solutions to halve nitrogen pollution from agriculture and the food system in Europe, including reducing meat and dairy consumption, fertiliser use and food waste.
Nitrogen, which is vital for plant growth, is present in animal excreta and synthetic fertilisers that are applied to land to boost crop production. But excessive and inefficient use of this nutrient means up to 80% of it leaks into the environment, mostly in various polluting forms of nitrogen: ammonia and nitrogen oxides, which are harmful air pollutants; ...
Huntsman Cancer Institute investigator receives award for metastatic breast cancer research
2023-12-20
Alana Welm, Ph.D., senior director of basic science at Huntsman Cancer Institute and professor of oncological sciences at the University of Utah (the U), received the 2023 American Association for Cancer Research (AACR) Outstanding Investigator Award for Breast Cancer Research.
“Dr. Welm is an exceptionally talented and internationally-recognized scientist, applying her discoveries to the development of improved breast cancer therapies,” says Neli Ulrich, Ph.D., MS, chief scientific officer and executive director of the comprehensive cancer center at Huntsman Cancer Institute and professor of population health sciences at the U. “She has a highly productive research ...
Endometrial cancer: New insights into a deadly disparity
2023-12-20
The numbers are stark and deeply troubling.
Endometrial cancer — which develops in the lining of the uterus (womb) and is sometimes called uterine cancer — is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 to more than 66,000 cases.
Deaths from the disease have also grown alarmingly in the same period, from less than 3,000 to more than 13,000 in the U.S. every year. And the trend line is not getting better.
“Endometrial cancer has been increasing at unprecedented levels over the past five years,” ...